Thin Film and Printed Battery Market

The global thin film and printed battery market size was USD 0.89 Billion in 2025 and is expected to register a revenue CAGR of 21.0% during the forecast period. Market revenue growth is supported by the miniaturisation of implantable medical devices and the expansion of pharmaceutical serialization and traceability requirements. Ilika confirmed in August 2025 that its manufacturing partner Cirtec Medical had successfully transferred Stereax solid-state battery technology to commercial production scale at its Lowell, Massachusetts facility, with initial Stereax M300 deliveries to lead customers targeted for 2025, following a ten-year manufacturing agreement the two companies signed in August 2023. Ilika's own assessment places the medical implant applications its Stereax platform targets, including peripheral nerve stimulators and continuous glucose monitors, inside a device market worth more than USD 40 billion, with the miniature battery component alone estimated at over USD 250 million. Thin-film solid-state micro-batteries, printed or screen-printed batteries, and hybrid laminated thin-film formats are the technology categories through which this demand is expressed, serving medical implants and neuromodulation, smart packaging and pharma compliance, industrial IoT and wireless sensors, and smart cards and RFID applications. These are some of the key factors driving revenue growth of the market.

Ilika, Cirtec Medical, Blue Spark Technologies, Enfucell, and Samsung SDI are among the commercial suppliers that constitute the thin film and printed battery market, spanning mm-scale rechargeable solid-state cells for implantable devices and screen-printed batteries for smart packaging and medical patches. Ilika's Stereax batteries are ultra-thin, millimeter-scale, rechargeable solid-state cells containing no liquid or polymer components, manufactured on a 6-inch glass wafer used as a non-functional substrate layer, and designed for thousands of recharge cycles with low nanoampere-scale leakage in a rectangular form factor similar to an integrated circuit. Ilika guided to approximately GBP 1.1 million in FY26 revenue, including first commercial Stereax electrode sales, alongside continued expansion of its separate Goliath large-format cell programme for automotive, defense, and e-bike evaluation.

However, the thin film and printed battery market remains constrained by the same characteristic that gives it commercial value: extremely small individual battery capacity. Novel therapeutic implantable devices using Ilika's technology can take three to five years to reach market at a development cost running into the tens of millions of dollars, meaning thin-film battery suppliers must sustain multi-year design-in relationships with medical device manufacturers before realising commercial battery shipment volume, a sales cycle far longer than the smart packaging and RFID applications served by the printed battery segment. Pharmaceutical serialization regulations, including the U.S. Drug Supply Chain Security Act and the EU's Falsified Medicines Directive, are also fragmented across jurisdictions, creating a complicated compliance landscape for smart packaging suppliers seeking to scale a single printed battery-enabled design across multiple regulated markets. These factors substantially limit thin film and printed battery market growth over the forecast period.

Based on technology, the global thin film and printed battery market is segmented into thin-film solid-state micro-batteries, printed or screen-printed batteries, and hybrid laminated thin-film formats. The thin-film solid-state micro-batteries segment commands the largest revenue share because its primary application, active implantable medical devices, commands the highest price per unit of any category in this market, with Ilika's own estimate placing the addressable miniature battery component alone at over USD 250 million within a broader implantable device market worth more than USD 40 billion.

The thin-film solid-state micro-batteries segment is also expected to register a rapid revenue growth rate in the global thin film and printed battery market over the forecast period. Ilika's exhibition of its Stereax platform at NANS 2026, the North American Neuromodulation Society's flagship annual meeting, alongside nearly 500 scientific abstracts on spinal cord stimulation, pain management, and implantable neurotechnologies, reflects growing clinical demand for smaller, safer implantable devices that solid-state thin-film batteries, with no liquid electrolyte and lower risk of leakage or thermal runaway than lithium-ion, are particularly well suited to power.

• 01What is the global thin film and printed battery market size in 2025 and what CAGR is expected during 2026-2035?
• 02What manufacturing milestone did Ilika and Cirtec Medical confirm in August 2025?
• 03How does Ilika size the addressable market for its Stereax miniature battery component relative to the broader implantable device market?
• 04What FY26 revenue guidance has Ilika given and what does it include?
• 05Which thin film and printed battery technology segment is expected to register the fastest revenue growth rate and why?
• 06What regulatory frameworks govern pharmaceutical smart packaging serialization in the United States and European Union?
• 07Why is North America the leading region for thin film and printed battery revenue and which facility drives that share?
• 08How long can novel implantable therapeutic devices take to reach market and what does that mean for thin-film battery sales cycles?
• 09What safety advantage do solid-state thin-film batteries offer over lithium-ion for implantable neurostimulation devices?
• 10Why does a fragmented multi-jurisdiction pharma compliance landscape raise design cost for printed battery-enabled smart packaging more than a single-market launch would?

This report covers the global thin film and printed battery market across all major segments and geographic regions. Primary research combines panel conversations with industry experts and is cross-referenced against company annual reports and government agency data. All market size figures use 2025 as the base year with a 2026-2035 forecast period.